From: Prognostic parameters for recurrence of papillary thyroid microcarcinoma
Patient No. | 1 | 2 | 3 | 4 | 5 | 6 | 7 |
---|---|---|---|---|---|---|---|
Age/Sex | 46/M | 32/M | 43/M | 38/F | 60/F | 44/F | 63/F |
Initial Surgical extent | TT, MRND | TT, CND | TT, MRND | TT, MRND | TT, MRND | TT, CND | TT, MRND |
I-131 Remnant ablation | done | Done | done | done | Done | done | done |
Just before recurrence | Â | Â | Â | Â | Â | Â | Â |
   sTg (ng/mL) | 58.6 | 34.4 | 17.3 | 13.8 | 33 | 21.5 | 20.7 |
   TgAb | negative | Negative | negative | positive | negative | negative | negative |
Disease free survival (months) | 9 | 11 | 13 | 24 | 31 | 35 | 43 |
Type of recurrence (Level of recurrent node confirmed by reoperation)c | regional (i/l II, III, IV) | regional (i/l III, SCN) | regional (i/l II, III, IV) | regional (i/l II, III, IV, SCN, VII) | regional (thyroid bed) | regional (i/l IV; c/l III, IV) | regional (i/l II, III, IV) |
Additional treatment | surgery, 131I | surgery, 131I | surgery, 131I, EBRT | surgery | surgery, 131I, EBRT | surgery, 131I | surgery, 131I |
Follow-up | Â | Â | Â | Â | Â | Â | Â |
   sTg (ng/mL) | UD | 12.6 | 1.1 | 8.7 | 944a | 12.4 | 40.0b |
   TgAb | negative | negative | negative | positive | negative | negative | negative |
Patient No. | 8 | 9 | 10 | 11 | 12 | 13 | 14 |
Age/Sex | 42/F | 50/F | 40/F | 43/F | 32/F | 40 M | 33/M |
Initial Surgical extent | TT, MRND | STT | LOB | LOB | LOB, CND | LOB, CND | LOB, CND |
I-131 Remnant ablation | done | not done | not done | not done | not done | not done | not done |
Just before recurrence | Â | Â | Â | Â | Â | Â | Â |
   sTg (ng/mL) | 1.1 | N/A | N/A | N/A | N/A | N/A | N/A |
   TgAb | neg | N/A | N/A | N/A | N/A | N/A | N/A |
Disease free survival (months) | 99 | 8 | 10 | 15 | 44 | 53 | 63 |
Type of recurrence (Level of recurrent node confirmed by reoperation)c | regional (i/l II, III) | regional (i/l III, IV) | local (c/l lobe) | local (c/l lobe) | local (c/l lobe) | local (c/l lobe) | local (c/l lobe) |
Additional treatment | surgery, 131I | surgery, 131I | follow-up loss | surgery, 131I | surgery, 131I | surgery, 131I | surgery, 131I |
Follow-up | Â | Â | Â | Â | Â | Â | Â |
   sTg (ng/mL) | UD | UD |  | UD | UD | UD | UD |
   TgAb | negative | positive |  | negative | negative | negative | negative |